Login

Interview Michel Finance, Director, Theradiag 00:00:00

Share On Facebook Share On Twitter

Interview Michel Finance, Director, Theradiag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
New Pacific Metals Corporation: Silver Focus and Growth in Bolivia
00:10:00
Enea CEO Jan Häglund explains why his company has been expanding its portfolio of data management tools and capabilities, highlighting Enea's strategic positioning in the market.
00:10:00
Scottie Resources: Unveiling Potential in BC's Golden Triangle
00:10:00
Continental Gold: Pioneering Modern-Day Large-Scale Gold Mining in Colombia
00:10:00
QC Copper and Gold: Unlocking Quebec's Copper Potential
00:10:00
Beyond the DeLorean: The Future of Impactful Businesses|Andrew Schoen,Partner,New Enterprise Associates (NEA)
00:10:00
Borosil Expands Solar Business to Compete with China and Malaysia | Shreevar Kheruka, CEO, Borosil Ltd.
00:10:00
His hub and spoke strategy in Quebec, recent drilling results, and drill targets for 2023|ERNEST MAST,CEO,Dore Copper Mining
00:10:00
Marine In Depth - Electronic Logbooks with Cesare D'Apì | Paolo d'Amico, CEO, d'Amico International Shipping SADIS:MIL
00:10:00
Insights into Agricultural Credit and Financial Inclusion: Philippe Brassac Discusses Banking Strategies | Philippe Brassac, CEO, Crédit Agricole.
00:10:00
Promising Study Reveals Cardiol Therapeutics' Subcutaneous Cannabidiol's Potential in Heart Failure Treatment| David Elsley, CEO, Cardiol Therapeutics Inc.
00:10:00
Global Growth Perspectives: Insights from Michael Edmonds at Tradex AGM | Michael Edmonds - Portfolio Manager, City of London Investment Management

© 2017 - Neuhu+